INTRACELLULAR Signalling following mitogenic stimulation of quiescent
cells involves the initiation of a phosphorylation cascade that leads
to the rapid and reversible activation of the mitogen-activated protei
n (MAP) kinases ERK1 and ERK2 (refs 1, 2). MAP kinase activation is me
diated by dual phosphorylation within the motif Thr-Glu-Tyr by MAP kin
ase kinase (MEK)(3). Following activation, the MAP kinases translocate
into the nucleus where they phosphorylate several transduction target
s, including transcription factors(4-7). We have previously identified
PAC1 as an immediate-early mitogen-inducible tyrosine phosphatase in
nuclei of T cells(8). Here we present several lines of evidence indica
ting that PAC1 is a physiologically relevant MAP kinase phosphatase. R
ecombinant PAC1 in vitro is a dual-specific Thr/Tyr phosphatase with s
tringent substrate specificity for MAP kinase. Constitutive expression
of PAC1 in vivo leads to inhibition of MAP kinase activity normally s
timulated by epidermal growth factor, phorbol myristyl acetate, or T-c
ell receptor crosslinking. The inactivation of MAP kinase by PAC1 resu
lts in inhibition of MAP kinase-regulated reporter gene expression.